Differences in kappa to lambda (κ:λ) ratios of serum and urinary free light chains
- 1 February 1998
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 111 (2), 457-462
- https://doi.org/10.1046/j.1365-2249.1998.00487.x
Abstract
SUMMARY: Free light chains (FLC) are a natural product of B lymphocytes and, as such, represent a quantifiable biomarker of cellular proliferation. Accurate measurement of the concentrations of these components in serum and urine provides a unique means of ascertaining B cell immunoglobulin synthesis during physiologic and, especially, pathologic states, where such information has important diagnostic and therapeutic implications. Previously, use of such quantitative assays has been limited due to the lack of potent serologic reagents specific for these components. We have immunized mice with κ- and λ-type monoclonal human light chains (Bence Jones proteins (BJP)) and have obtained monoclonal antibodies (MoAbs) that differentiate between unbound and bound light chains. These highly specific MoAbs were used to measure by ELISA the concentrations of FLC in the serum of 22 normal individuals and in urine from 16 of these subjects. The mean serum κ and λ FLC concentrations were found to be 16.6 ± 6.1 μg/ml and 33.8 ± 14.8 μg/ml, respectively. In contrast, the values for urinary κ and λ FLC were 2.96 ± 1.84 μg/ml and 1.07 ± 0.69 μg/ml, respectively. In each case studied, the serum κ:λ ratio was consistently less than that of urine (mean values, serum ≈ 1:2; urine ≈ 3:1). That the rate of synthesis of λ-type FLC exceeded that of κ was evidenced in assays of culture fluid supernatants of unstimulated normal peripheral blood mononuclear cells (PBMC), where the mean κ:λ ratio was determined to be 1:1.4. Metabolic studies in which mice were injected with pools of κ- and λ-type BJP prepared in ratios of 1:1, 1:2 and 1:4 demonstrated that, regardless of the proportion, κ FLC were preferentially excreted. Our studies provide the first evidence that λ FLC are secreted by normal PBMC at a greater rate than are κ FLC, as evidenced in biosynthetic studies and by measurement of their serum concentrations. Further, we posit that quaternary structural differences between the two light-chain isotypes may account for the predominance of κversusλ components in urine.Keywords
This publication has 37 references indexed in Scilit:
- Novel Immunization Protocol and ELISA Screening Methods Used to Obtain and Characterize Monoclonal Antibodies Specific for Human Light Chain Variable-Region SubgroupsHybridoma, 1993
- Measurement of free kappa and lambda chains in serum and the significance of their ratio in patients with multiple myelomaBritish Journal of Haematology, 1992
- Immunoturbidimetric assay for estimating free light chains of immunoglobulins in urine and serum.Journal of Clinical Pathology, 1991
- Urinary excretion of kappa light chains in patients with diabetes mellitusKidney International, 1990
- Clinical relapse in systemic lupus erythematosus: Correlation with antecedent elevation of urinary free light-chain immunoglobulinJournal of Clinical Immunology, 1989
- Restriction of blood and marrow CLL-B cells to free L-chain IG secretion: Implication for normal B-cell function and controlAmerican Journal of Hematology, 1988
- Regulatory idiotopes. Induction of idiotype-recognizing helper T cells by free light and heavy chains.The Journal of Experimental Medicine, 1984
- T helper cells recognize an idiotope located on peptide 88-114/117 of the light chain variable domain of an isologous myeloma protein (315).The Journal of Experimental Medicine, 1983
- Free Light Chains of Immunoglobulins in Serum from Patients with Rheumatoid Arthritis, Sarcoidosis, Chronic Infections and Pulmonary CancerActa Medica Scandinavica, 1981
- Increase of L‐chain proteins in the sera of patients with systemic lupus erythematosus and the synovial fluids of patients with peripheral rheumatoid arthritisArthritis & Rheumatism, 1966